About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

MannKindís Inhaled Insulin Device Rejected by FDA

by Kathy Jones on January 20, 2011 at 9:24 PM
Font : A-A+

 MannKindís Inhaled Insulin Device Rejected by FDA

In a major blow to California based pharmaceutical company, MannKind Corp, the US Food and Drug Administration (FDA) has rejected its new inhaled insulin device for diabetic patients.

According to the company, the FDA has asked it to conduct two new trials for the device, known as Afrezza.

Advertisement

MannKind released a statement that it will be complying with FDA's directive and has already started the new trials and expressed its confidence that it will satisfy FDA's request.

Commenting on the decision, the chief executive officer of MannKind Corp, Alfred Mann said that he was disappointed over the decision. "We are encouraged that the FDA is asking for clinical studies only to confirm the bridging and handling of the next-generation device in order to compare it to the device used in our extensive clinical program. We remain committed to working with the FDA to make Afrezza available to people with diabetes", he added.


Source: Medindia
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Diabetes - Essentials Insulin Delivery Devices Gestational diabetes Type 2 Diabetes Diabetes - Foot Care Diabesity Diabetes in Pets Diabetes Facts and Figures Insulin Hormone Hypoglycemia (Low Blood Sugar) 

Most Popular on Medindia

Indian Medical Journals Drug Side Effects Calculator Sanatogen Blood Donation - Recipients Iron Intake Calculator Calculate Ideal Weight for Infants Blood Pressure Calculator Turmeric Powder - Health Benefits, Uses & Side Effects Sinopril (2mg) (Lacidipine) Daily Calorie Requirements
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

MannKindís Inhaled Insulin Device Rejected by FDA Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests